Published in AIDS on November 19, 2004
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med (2007) 2.93
Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis (2012) 2.51
Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis (2010) 2.35
Antiretrovirals in pregnancy: a note of caution. J Infect Dis (2012) 1.49
Children and HIV/AIDS: from research to policy and action in resource-limited settings. AIDS (2008) 1.49
Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial. Pilot Feasibility Stud (2016) 1.40
Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception. Sex Transm Infect (2008) 1.31
Combination antiretroviral use and preterm birth. J Infect Dis (2012) 1.25
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials (2008) 1.22
Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc (2011) 1.22
Influence of infection during pregnancy on fetal development. Reproduction (2013) 1.20
Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment. PLoS One (2011) 1.12
Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod (2012) 1.12
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial. Antivir Ther (2008) 1.04
Increased risk of severe infant anemia after exposure to maternal HAART, Botswana. J Acquir Immune Defic Syndr (2011) 0.94
Routine antenatal HIV testing: the responses and perceptions of pregnant women and the viability of informed consent. A qualitative study. J Med Ethics (2007) 0.94
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe. Antivir Ther (2011) 0.92
Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations. Antimicrob Agents Chemother (2011) 0.90
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.87
Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med (2010) 0.87
Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy. Infect Dis Obstet Gynecol (2012) 0.86
Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025. J Pediatric Infect Dis Soc (2012) 0.85
Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy. J Infect Dis (2016) 0.84
The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children. J Int AIDS Soc (2015) 0.79
Association of Body Mass Index of HIV-1-Infected Pregnant Women and Infant Weight, Body Mass Index, Length, and Head Circumference: The NISDI Perinatal Study. Nutr Res (2007) 0.79
Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges. Expert Opin Drug Saf (2016) 0.79
Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study. BJOG (2014) 0.78
Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting? J Int AIDS Soc (2015) 0.78
German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res (2009) 0.78
Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy. Infect Dis Obstet Gynecol (2013) 0.78
Duration of cART Before Delivery and Low Infant Birthweight Among HIV-Infected Women in Lusaka, Zambia. J Acquir Immune Defic Syndr (2016) 0.78
Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study. Eur J Clin Microbiol Infect Dis (2014) 0.77
Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population. Pediatr Infect Dis J (2015) 0.77
Mitochondrial toxicity in human pregnancy: an update on clinical and experimental approaches in the last 10 years. Int J Environ Res Public Health (2014) 0.77
The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs. Front Immunol (2016) 0.76
Effects of maternal and infant characteristics on birth weight and gestation length in a colony of rhesus macaques (Macaca mulatta). Comp Med (2008) 0.76
Ten years of experience in the prevention of mother-to-child human immunodeficiency virus transmission in a university teaching hospital. Korean J Pediatr (2014) 0.75
Getting to 90-90-90 in paediatric HIV: What is needed? J Int AIDS Soc (2015) 0.75
Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women. PLoS One (2015) 0.75
Preterm Birth and Low Birth Weight after In Utero Exposure to Antiretrovirals Initiated during Pregnancy in Yaoundé, Cameroon. PLoS One (2016) 0.75
Incident pregnancy and pregnancy outcomes among HIV-infected women in Uganda and Zimbabwe. Int J Gynaecol Obstet (2015) 0.75
Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy. HIV AIDS (Auckl) (2009) 0.75
Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries. J Infect (2014) 0.75
Mitochondrial toxicity and caspase activation in HIV pregnant women. J Cell Mol Med (2016) 0.75
Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis. Reprod Health (2016) 0.75
Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol. Pilot Feasibility Stud (2017) 0.75
Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet (2007) 9.92
High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science (2013) 8.24
Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol (2007) 6.81
Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis (2004) 5.93
Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study. Lancet (2011) 5.58
Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study. AIDS (2007) 5.54
Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science (2013) 5.01
High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS (2008) 4.05
Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ (2009) 3.77
Cohort profile: Hlabisa HIV treatment and care programme. Int J Epidemiol (2010) 3.72
Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol (2007) 3.69
Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis (2011) 3.63
Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. Int J Epidemiol (2009) 3.42
Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology (2014) 3.39
The socioeconomic determinants of HIV incidence: evidence from a longitudinal, population-based study in rural South Africa. AIDS (2007) 3.02
Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS (2007) 3.01
Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes. AIDS (2008) 2.96
Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2011) 2.96
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA (2002) 2.91
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr (2014) 2.79
Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ (2010) 2.72
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol (2011) 2.41
HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS One (2008) 2.35
Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm (2009) 2.34
Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20
Lack of a decline in HIV incidence in a rural community with high HIV prevalence in South Africa, 2003-2007. AIDS Res Hum Retroviruses (2009) 2.09
Women's groups' perceptions of maternal health issues in rural Malawi. Lancet (2006) 2.09
Verbal autopsy-based cause-specific mortality trends in rural KwaZulu-Natal, South Africa, 2000-2009. Popul Health Metr (2011) 1.98
Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. J Acquir Immune Defic Syndr (2007) 1.97
Gender, migration and HIV in rural KwaZulu-Natal, South Africa. PLoS One (2010) 1.96
Intervention to promote exclusive breast-feeding for the first 6 months of life in a high HIV prevalence area. AIDS (2008) 1.95
Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis (2007) 1.88
Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Curr HIV Res (2007) 1.85
In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff (Millwood) (2012) 1.84
Poor long-term outcomes for cryptococcal meningitis in rural South Africa. S Afr Med J (2011) 1.83
Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health (2007) 1.82
Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS (2013) 1.82
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med (2013) 1.73
HIV prevention for South African youth: which interventions work? A systematic review of current evidence. BMC Public Health (2010) 1.71
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS One (2011) 1.67
HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis. Epidemiology (2010) 1.63
Migration, sexual behaviour, and HIV risk: a general population cohort in rural South Africa. Lancet HIV (2015) 1.63
Coming home to die? The association between migration and mortality in rural South Africa. BMC Public Health (2009) 1.62
Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration. Int J Epidemiol (2007) 1.60
Population uptake of antiretroviral treatment through primary care in rural South Africa. BMC Public Health (2010) 1.58
Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact? AIDS (2010) 1.56
Estimating the number of vertically HIV-infected children eligible for antiretroviral treatment in resource-limited settings. Int J Epidemiol (2007) 1.56
Breast-feeding and Transmission of HIV-1. J Acquir Immune Defic Syndr (2004) 1.56
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS (2012) 1.55
Starting a home and mobile HIV testing service in a rural area of South Africa. J Acquir Immune Defic Syndr (2012) 1.54
The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr (2012) 1.53
Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants. Clin Infect Dis (2011) 1.53
Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern? Drug Saf (2007) 1.52
Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatr (2005) 1.52
Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. PLoS One (2012) 1.48
CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis (2006) 1.46
The tuberculosis challenge in a rural South African HIV programme. BMC Infect Dis (2010) 1.46
Mortality levels and trends by HIV serostatus in rural South Africa. AIDS (2007) 1.46
Refining the criteria for stalled fertility declines: an application to rural KwaZulu-Natal, South Africa, 1990-2005. Stud Fam Plann (2008) 1.45
Social exposure to an antiretroviral treatment programme in rural KwaZulu-Natal. Trop Med Int Health (2011) 1.45
Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults. PLoS One (2011) 1.43
Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa. PLoS One (2012) 1.41
Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS (2005) 1.41
Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics (2012) 1.40
Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts. PLoS One (2009) 1.39
Ageing with HIV in South Africa. AIDS (2011) 1.37
Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: comparing statistical methods. Am J Epidemiol (2003) 1.33
Do age-disparate relationships drive HIV incidence in young women? Evidence from a population cohort in rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2014) 1.33
Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? J Acquir Immune Defic Syndr (2005) 1.32
Age-gaps in sexual partnerships: seeing beyond 'sugar daddies'. AIDS (2011) 1.29
Age-related standards for total lymphocyte, CD4+ and CD8+ T cell counts in children born in Europe. Pediatr Infect Dis J (2005) 1.23
High uptake of HIV testing for tuberculosis patients in an integrated primary health care HIV/TB programme in rural KwaZulu-Natal. S Afr Med J (2010) 1.22
Breastfeeding, HIV status and weights in South African children: a comparison of HIV-exposed and unexposed children. AIDS (2010) 1.22
Preventing postnatal transmission of HIV-1 through breast-feeding: modifying infant feeding practices. J Acquir Immune Defic Syndr (2004) 1.21
Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa*. Trop Med Int Health (2009) 1.21
Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr (2004) 1.20
Mother-to-child transmission of HIV infection and its prevention. Curr HIV Res (2003) 1.20
Unpacking the recommended indicator for concurrent sexual partnerships. AIDS (2012) 1.20
Primary drug resistance in South Africa: data from 10 years of surveys. AIDS Res Hum Retroviruses (2012) 1.20
An investigation of factors associated with the health and well-being of HIV-infected or HIV-affected older people in rural South Africa. BMC Public Health (2012) 1.19
Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso. J Acquir Immune Defic Syndr (2010) 1.18
Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J (2013) 1.17
HIV drugs for treatment, and for prevention. Lancet (2010) 1.17
MaiMwana women's groups: a community mobilisation intervention to improve mother and child health and reduce mortality in rural Malawi. Malawi Med J (2010) 1.17
Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials. J Acquir Immune Defic Syndr (2004) 1.16
The prevalence and clinical presentation of antenatal depression in rural South Africa. J Affect Disord (2011) 1.16
Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol (2006) 1.16
The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis. Pediatr Infect Dis J (2012) 1.15
Amino acids and mTOR mediate distinct metabolic checkpoints in mammalian G1 cell cycle. PLoS One (2013) 1.15
The social dynamics of consent and refusal in HIV surveillance in rural South Africa. Soc Sci Med (2012) 1.14
Treating HIV-infected mothers reduces under 5 years of age mortality rates to levels seen in children of HIV-uninfected mothers in rural South Africa. Antivir Ther (2012) 1.13
Reproductive experience of HIV-infected women living in Europe. Hum Reprod (2008) 1.12